Castle Biosciences Inc
Research Castle Biosciences Inc (CSTL) on Bullrun: market cap USD 1.07B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCSTL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 1.07B
- Financial periodQ2 2026
- RevenueUSD 103.55M
- Net income-USD 2.06M
- Free cash flowUSD 6.55M
- Gross margin77.1%
Valuation Snapshot
latest market cap is USD 1.07B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 344.23M | -USD 24.16M | USD 28.33M | 79.4% | -0.83 | USD 116.73M | USD 10.06M | USD 470.87M |
| FY2024 | USD 332.07M | USD 18.25M | USD 36.54M | 81.9% | 0.62 | USD 119.71M | USD 10.02M | USD 455.84M |
| FY2023 | USD 219.79M | -USD 57.47M | -USD 19.25M | 79.5% | -2.14 | USD 98.84M | USD 0 | USD 391.27M |
| FY2022 | USD 137.04M | -USD 67.14M | -USD 47.29M | 76.6% | -2.58 | USD 122.95M | USD 7.69M | USD 399.15M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.07B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.15B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 759.08M | 43.7 | n/a | n/a |
| 2023 | 2023-12-29 | USD 580.73M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 620.32M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.09B | n/a | n/a | n/a |
About Castle Biosciences Inc
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Castle Biosciences Inc's market cap?
Castle Biosciences Inc's market capitalization is USD 1.07B.
What does Castle Biosciences Inc do?
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma.